Ra Pharmaceuticals, Inc. Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ra Pharmaceuticals, Inc. for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2017 | RARX | Ra Pharmaceuticals ... | Lettmann Jason | Director | Option Exercise | A | 22.37 | 15,000 | 335,550 | 15,000 | |
| Jun 22 2017 | RARX | Ra Pharmaceuticals ... | Mathers Edward T | Director | Option Exercise | A | 22.37 | 15,000 | 335,550 | 15,000 | |
| Jun 22 2017 | RARX | Ra Pharmaceuticals ... | Heft Robert | Director | Option Exercise | A | 22.37 | 15,000 | 335,550 | 15,000 | |
| Jun 22 2017 | RARX | Ra Pharmaceuticals ... | Shah Rajeev M. | Director | Option Exercise | A | 22.37 | 15,000 | 335,550 | 15,000 | |
| Jun 22 2017 | RARX | Ra Pharmaceuticals ... | PEARSON TIMOTHY R | Director | Option Exercise | A | 22.37 | 15,000 | 335,550 | 15,000 | |
| Jun 22 2017 | RARX | Ra Pharmaceuticals ... | RA CAPITAL MANAGEMENT, LLC | Director | Option Exercise | A | 22.37 | 15,000 | 335,550 | 15,000 | |
| Jun 20 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 22.02 | 3,220 | 70,899 | 2,251,457 | 2.3 M to 2.3 M (-0.14 %) |
| Jun 20 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 21.24 | 53,200 | 1,130,207 | 2,254,677 | 2.3 M to 2.3 M (-2.31 %) |
| Jun 12 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 22.00 | 700 | 15,400 | 2,307,877 | 2.3 M to 2.3 M (-0.03 %) |
| Jun 08 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 22.11 | 4,840 | 106,999 | 2,308,577 | 2.3 M to 2.3 M (-0.21 %) |
| Jun 08 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 22.98 | 7,274 | 167,161 | 2,313,417 | 2.3 M to 2.3 M (-0.31 %) |
| Jun 06 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 23.11 | 4,780 | 110,488 | 2,320,691 | 2.3 M to 2.3 M (-0.21 %) |
| Jun 06 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 23.47 | 14,867 | 348,949 | 2,325,471 | 2.3 M to 2.3 M (-0.64 %) |
| Jun 02 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 23.89 | 10,722 | 256,176 | 2,340,338 | 2.4 M to 2.3 M (-0.46 %) |
| Jun 02 2017 | RARX | Ra Pharmaceuticals ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 23.94 | 35,539 | 850,896 | 2,351,060 | 2.4 M to 2.4 M (-1.49 %) |